Literature DB >> 22568855

New trends for the medical treatment of endometriosis.

Ana Luiza L Rocha1, Fernando M Reis, Felice Petraglia.   

Abstract

INTRODUCTION: Endometriosis is a benign sex hormone-dependent gynecological disease, characterized by the presence and growth of endometrial tissue outside the uterus; it affects 10% of women of reproductive age and is associated with infertility and pain. Treatment of endometriosis involves conservative or radical surgery, or medical therapies. The goals for endometriosis treatment may be the relief of pain and/or a successful pregnancy achievement in infertile patients. Treatment must be individualized with a multidisciplinary approach. The classical treatments carry adverse side effects and in some cases a negative impact on quality of life. New agents promise a distinct perspective in endometriosis treatment. AREAS COVERED: The aim of this paper is to systematically review the literature evidence of new medical treatments for endometriosis, defined as pharmacological treatments not yet commonly available and currently under investigation. EXPERT OPINION: These new medical therapies would be used associated with surgical treatment and, in the future, will render possible the association of hormone therapy with non-hormonal treatment for endometriosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568855     DOI: 10.1517/13543784.2012.683783

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  12 in total

1.  PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.

Authors:  Dan I Lebovic; Shahryar K Kavoussi; JeHoon Lee; Sakhila K Banu; Joe A Arosh
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

Review 2.  Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.

Authors:  Matthew Latham Macer; Hugh S Taylor
Journal:  Obstet Gynecol Clin North Am       Date:  2012-12       Impact factor: 2.844

3.  Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats.

Authors:  Zhixing Jin; Li Wang; Zhiling Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-27       Impact factor: 2.629

4.  Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model.

Authors:  Ruihua Zhong; Aying Ma; Jianping Zhu; Guoting Li; Shuwu Xie; Zhao Li; Youlun Gui; Yan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-11       Impact factor: 2.629

5.  Baicalein reduces endometriosis by suppressing the viability of human endometrial stromal cells through the nuclear factor-κB pathway in vitro.

Authors:  Zhixing Jin; Jianqin Huang; Zhiling Zhu
Journal:  Exp Ther Med       Date:  2017-08-01       Impact factor: 2.447

Review 6.  Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care.

Authors:  Laura Buggio; Giussy Barbara; Federica Facchin; Maria Pina Frattaruolo; Giorgio Aimi; Nicola Berlanda
Journal:  Int J Womens Health       Date:  2017-05-02

7.  Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffness.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

Review 8.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

9.  Angiogenesis and endometriosis.

Authors:  Ana Luiza L Rocha; Fernando M Reis; Robert N Taylor
Journal:  Obstet Gynecol Int       Date:  2013-05-26

10.  Gamma-Synuclein Levels Are Elevated in Peritoneal Fluid of Patients with Endometriosis.

Authors:  Noémi Csibi; Réka Brubel; Noémi Dobó; Katalin Viola Mészáros; Attila Molvarec; Péter Lukovich; János Rigó; Attila Z Bokor
Journal:  Med Sci Monit       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.